You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 148 No. 5, May 1988 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Thyroid and Pituitary Function Following Allogeneic Bone Marrow Transplantation

Serafino Lio, MD; William Arcese, MD; Giuseppe Papa, MD; Massimino D'Armiento, MD

Arch Intern Med. 1988;148(5):1066-1071.


Abstract

• Thyroid function was evaluated in 13 consecutive patients with chronic myelogenous leukemia to verify in allogeneic bone marrow transplantation if the fractionated irradiation protocol with low dose rate, previously applied to reduce the damage to various organs, also prevents the 43% incidence of primary hypothyroidism that occurs after the administration of single dose with higher dose rate. Following bone marrow transplantation, decreased plasma levels of total thyroxine and triiodothyronine and impaired response of thyrotropic cells to thyrotropin-releasing hormone were observed. These alterations reverted to normal in nine months and none of the patients was hypothyroid at the end of follow-up. The damage to thyrotropic cells appears to be selective because the secretion of prolactin was not impaired and that of gonadotropins even increased, as a consequence of gonadal failure. Longer follow-up is needed to determine if this irradiation protocol, which prevents the complication of permanent primary hypothyroidism and does not cause any destruction of thyroid cells, may increase the risk of irradiation-related thyroid tumors.

(Arch Intern Med 1988;148:1066-1071)



Author Affiliations

From the Institute of Experimental Medicine CNR, Rome (Dr Lio); Institute of Hematology, Universities "La Sapienza" (Dr Arcese) and "Tor Vergata" Rome (Dr Papa); and Institute of Endocrinology, University of L'Aquila, L'Aquila, Italy (Dr D'Armiento).


Footnotes

Accepted for publication Dec 21, 1987.

Reprint requests to Chair of Endocrinology, University of L'Aquila, Collemaggio, 67100 L'Aquila, Italy (Dr D'Armiento).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The immune system as a regulator of thyroid hormone activity.
Klein
Exp. Biol. Med. 2006;231:229-236.
ABSTRACT | FULL TEXT  

Allogeneic Hematopoietic Stem Cell Transplantation: Complications and Results
Tabbara et al.
Arch Intern Med 2002;162:1558-1566.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1988 American Medical Association. All Rights Reserved.